According to LENZ Therapeutics's latest financial reports the company's current EPS (TTM) is -2,52ย โฌ. In 2023 the company made an earnings per share (EPS) of -2,52ย โฌ a decrease over its 2022 EPS that were of -0,39ย โฌ.